0001093557-17-000006.txt : 20170111 0001093557-17-000006.hdr.sgml : 20170111 20170111193136 ACCESSION NUMBER: 0001093557-17-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170109 FILED AS OF DATE: 20170111 DATE AS OF CHANGE: 20170111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VALDES JORGE A CENTRAL INDEX KEY: 0001343856 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 17523787 MAIL ADDRESS: STREET 1: C/O DEXCOM INC STREET 2: 5555 OBERLIN DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-01-09 0 0001093557 DEXCOM INC DXCM 0001343856 VALDES JORGE A 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 CTO Common Stock 2017-01-09 4 M 0 7000 7.79 A 79334 D Common Stock 2017-01-09 4 S 0 7000 63.0232 D 72334 D Common Stock 2017-01-09 4 M 0 417 7.63 A 72751 D Common Stock 2017-01-09 4 S 0 417 63.4875 D 72334 D Common Stock 2017-01-09 4 M 0 900 3.19 A 73234 D Common Stock 2017-01-09 4 S 0 900 63.3118 D 72334 D Common Stock 2017-01-09 4 M 0 2583 7.63 A 74917 D Common Stock 2017-01-09 4 S 0 2583 62.8291 D 72334 D Common Stock 3499 I by Trust Incentive Stock Option (right to buy) 7.63 2017-01-09 4 M 0 417 63.4875 D 2009-05-19 2018-05-19 Common Stock 417 10000 D Incentive Stock Option (right to buy) 7.79 2017-01-09 4 M 0 7000 63.0232 D 2008-08-02 2017-08-02 Common Stock 7000 0 D Non-Qualified Stock Option (right to buy) 7.63 2017-01-09 4 M 0 2583 62.8291 D 2009-05-19 2018-05-19 Common Stock 2583 0 D Non-Qualified Stock Option (right to buy) 2017-01-09 4 M 0 900 63.0 D 2009-12-11 2018-12-11 Common Stock 900 100 D On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan. This transaction was executed in multiple trades at prices ranging from $62.48 to $63.71. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017. This transaction was executed in multiple trades at prices ranging from $63.37 to $63.65. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. This transaction was executed in multiple trades at prices ranging from $63.17 to $63.37. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. This transaction was executed in multiple trades at prices ranging from $62.49 to $63.17. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee. Conversion or exercise price of derivative security is $3.19. By: Kevin Sun For: Jorge A. Valdes 2017-01-11